Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorouracil 3Oxaliplatin 2Leucovorin 2Cholecalciferol 2Cetuximab 2sodium thiosulfate 1nilotinib 1gallium 68 PSMA-11 1epigallocatechin gallate 1delta-8-tetrahydrocannabinol 1clevudine 1X-Rays 1Vaccines 1Tea 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Receptor Protein-Tyrosine Kinases 1Radiotherapy 1Platinum 1Pentoxifylline 1Panitumumab 1Microscopy, Electron 1Metastasectomy 1Irinotecan 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Folfox protocol 1Fluorodeoxyglucose F18 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Colonic Neoplasms × Cannabidiol × Clear all
NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

City of Hope Medical Center

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡